Table 4.
Areas under the ROC curve for WHO classification and PD-NLR for predicting OS and DFS in patients with surgically resected neuroendocrine tumors in the head of the pancreas
| Variable | OS | DFS | ||
|---|---|---|---|---|
| Area under the ROC curve (95% CI) | P | Area under the ROC curve (95% CI) | P | |
| PD-NLR | 0.886 (0.788–0.985) | < 0.001 | 0.889 (0.795–0.983) | < 0.001 |
| PD | 0.785 (0.641–0.929) | 0.001 | 0.757 (0.618–0.896) | 0.001 |
| NLR (≤ 3.1/ > 3.1) | 0.772 (0.619–0.925) | 0.002 | 0.791 (0.655–0.927) | < 0.001 |
| WHO classification | 0.818 (0.699–0.938) | < 0.001 | 0.858 (0.761–0.955) | < 0.001 |
ROC Receiver operating characteristic, OS Overall survival, DFS Disease-free survival, PD Main pancreatic duct dilation, NLR Neutrophil-to-lymphocyte ratio. P-values < 0.05, marked in bold font, indicate statistical significance